We are the leading funder of brain tumour research in the UK, spending over £18.3 million to date on pioneering projects that will help adults and children with brain tumours.
We spend 80p in every £1 donated on our charitable aims, so the more we raise, the more we will invest in research. We fund research through a competitive, fair and transparent process of best practice called peer review to ensure we only select the very best research that will have a real impact on those affected by brain tumours.
This research involves innovative approaches that could change our understanding, diagnosis and management of brain tumours.
This research acknowledges the importance of international and interdisciplinary team approaches to accelerate research.
This scheme has been established to focus research onto reducing the burden and harm to those diagnosed with a brain tumour.
We're partnering with the Structural Genomics Consoritum, funding two researchers who will be searching for new drugs.